Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study
The DOI matches its Crossref record.
Abstract
BACKGROUND: The epidemiology of human herpesvirus 6 (HHV-6) encephalitis after allogeneic hematopoietic cell transplantation (HCT) and its relationship with HHV-6 reactivation have not been sufficiently characterized. METHODS: This prospective, multicenter study of 230 allogeneic HCT recipients investigated the epidemiology of HHV-6 reactivation and HHV-6 encephalitis. Plasma HHV-6 DNA load was prospectively evaluated twice weekly until 70 days after HCT. RESULTS: Cumulative incidence of positive HHV-6 DNA and high-level HHV-6 reactivation (plasma HHV-6 DNA ≥10(4) copies/mL) at day 70 after HCT was 72.2% and 37.0%, respectively. Multivariate analysis identified myeloablative conditioning (hazard ratio [HR], 1.9; P = .004), umbilical cord blood transplantation (UCBT) (HR, 2.0; P = .003), and male sex (HR, 1.6; P = .04) as risk factors for displaying high-level HHV-6 reactivation. HHV-6 encephalitis occurred in 7 patients, and cumulative incidence at day 70 was 3.0%. None of the144 patients without high-level HHV-6 reactivation and 7 of 86 patients (8.1%) with high-level HHV-6 reactivation developed HHV-6 encephalitis (P = .0009). Prevalence of HHV-6 encephalitis was significantly higher among patients receiving UCBT than in patients with other sources (cumulative incidence at day 70, 7.9% vs 1.2%, P = .008). In each of 7 patients with HHV-6 encephalitis, central nervous system (CNS) symptoms developed concomitant with peak plasma HHV-6 DNA (range, 21 656-433 639 copies/mL). CONCLUSIONS: High levels of plasma HHV-6 DNA are associated with higher risk of HHV-6 encephalitis. UCBT is a significant risk factor for HHV-6 encephalitis. HHV-6 encephalitis should be considered if CNS dysfunction develops concomitant to high-level plasma HHV-6 DNA after allogeneic HCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Green, D. A., Pereira, M., Miko, B., Radmard, S., Whittier, S., & Thakur, K. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy288 · Cited by 110
“Studies have shown a wide range of CSF viral loads from 600–600 000 copies/mL among HSCT recipients with HHV-6 encephalitis, with a median of about 11 000–16 000 copies/mL [3, 11, 12].”
BackgroundInfluentialHuman Herpesviruses 6A, 6B, and 7
Agut, H., Bonnafous, P., & Gautheret-Dejean, A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0007-2015 · Cited by 87
Human herpesvirus 6 encephalitis in immunocompetent and immunocompromised hosts
Berzero, G., Campanini, G., Vegezzi, E., Paoletti, M., Pichiecchio, A., Simoncelli, A. M., Colombo, A. A., Bernasconi, P., Borsani, O., Di Matteo, A., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000942 · Cited by 76
Rebechi, M. T., Bork, J. T., & Riedel, D. J. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab470 · Cited by 37
Slenker, A. K., Royer, T. L., & Villalobos, T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz058 · Cited by 19
Metadata
- Authors
- Ogata, M., Satou, T., Kadota, J.-I., Saito, N., Yoshida, T., Okumura, H., Ueki, T., Nagafuji, K., Kako, S., Uoshima, N., Tsudo, M., Itamura, H., & Fukuda, T.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-30
- Volume
- 57
- Issue
- 5
- Pages
- 671-681
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2132387457
- Cited by
- 196
- References
- 0
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study. https://app.cochat.ai/papers/10.1093/cid/cit358
- The paper
- Ogata, M., Satou, T., Kadota, J.-I., Saito, N., Yoshida, T., Okumura, H., Ueki, T., Nagafuji, K., Kako, S., Uoshima, N., Tsudo, M., Itamura, H., & Fukuda, T. (2013). Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cit358
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.